small molecule tyrosine

Related by string. * smaller . Smaller . Smalls . SMALL : Small Cap Index . Chris Smalling . Small Cap Value . Small Cap Growth / Molecules . Molecule . molecules : small molecule therapeutics . small molecule inhibitor . stranded RNA molecules . dye molecules / Tyrosine : VEGF receptor tyrosine kinases . Bruton tyrosine kinase Btk . Bruton tyrosine kinase . receptor tyrosine kinases RTKs * *

Related by context. Frequent words. (Click for all words.) 75 liposomal formulation 72 proteasome inhibitor 71 orally bioavailable 71 Factor VIIa 70 tyrosine kinase inhibitor 70 multi kinase inhibitor 69 Aliskiren 69 Carfilzomib 69 vascular disrupting agent 69 Erlotinib 68 polymerase inhibitor 68 CCX# 68 targeting CD# 68 small molecule inhibitor 68 Dasatinib 68 Gefitinib 68 Denufosol 67 MEK inhibitor 67 angiogenesis inhibitor 67 Panzem R 67 PEG SN# 67 TLR9 agonist 67 HCV protease 67 selectively inhibit 67 bleomycin 67 Drug Candidate 67 selective inhibitor 67 Recombinant Human 67 induces apoptosis 67 mTOR inhibitor 67 kinase inhibitor 67 hypoxia inducible factor 67 partial agonist 66 proteasome inhibitors 66 selectively inhibits 66 PSN# [002] 66 immunomodulating 66 Epratuzumab 66 anticancer compound 66 Thiarabine 66 Daclizumab 66 enzyme inhibitor 66 CYC# 66 recurrent glioblastoma 66 humanized antibody 66 lung fibrosis 66 IMC #B 66 Initiate Phase 66 immune modulator 65 Losartan 65 Irinotecan 65 Nexavar ® 65 Aurora kinase 65 neuroprotective properties 65 Voreloxin 65 PEGylated 65 epothilone 65 Vandetanib 65 potent inhibitor 65 Dapagliflozin 65 Golimumab 65 antiproliferative 65 BN# [002] 65 Laquinimod 65 FGFR 65 Bortezomib 65 CA4P 65 alkylating agents 65 novel anticancer 65 Doxorubicin 65 exon skipping 65 receptor agonists 65 secondary hyperparathyroidism 65 Pivotal Phase III 65 Hsp# inhibitors 65 intravenously administered 65 Mipomersen 65 direct thrombin inhibitor 65 Capecitabine 65 Taxol ® 65 liposomal 65 refractory chronic lymphocytic 65 Nanobody 65 anti fibrotic 64 Tesetaxel 64 induce apoptosis 64 SAR# [004] 64 pegylated 64 Monoclonal Antibody 64 ganetespib 64 enzastaurin 64 injectable formulation 64 DP b# 64 MNTX 64 ALN TTR# 64 luteinizing hormone releasing 64 estrogen receptor beta 64 Combination therapy 64 inhibitory effects 64 antithrombotic 64 Phase III Clinical Trial

Back to home page